Originally developed to treat type 2 diabetes, theyve since gained FDA approval for weight management in adults and, more recently, some teens
through the combination of sulfydryl and free radicals in vivo, the free radicals can be directly reduced and converted into easily metabolized acid substances, so that the excretion of the free radicals is accelerated, and the damage of the free radicals to important organs can be resisted
the glucagon arm additionally nudges energy expenditure and hepatic fat handling upward
First, diabetes blunts weight loss by roughly 6 to 7 percentage points versus non-diabetic obesity at the same dose, because long-standing high glucose dampens the metabolic cascade the drug works through. Second, the 10-to-15 mg step keeps adding weight loss in every band
Analysis by Year of Partnership 9.3.2